-
公开(公告)号:US20230302264A1
公开(公告)日:2023-09-28
申请号:US18022245
申请日:2021-09-02
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Scott R. Gibson , Scott Castanon , Robert Eisele , Dylann Ceriani
CPC classification number: A61M31/002 , A61M37/0015
Abstract: A swallowable drug delivery device includes a capsule and a tissue attachment member. The capsule may contain a drug and may be sized to pass through at least a portion of the gastrointestinal tract of a patient. The tissue attachment member may be coupled to the capsule. In an initial state, the tissue attachment member may allow the capsule to pass through the at least a portion of the gastrointestinal tract of the patient. In an activated state, the tissue attachment member is configured to at least selectively attach the capsule to a wall of the gastrointestinal tract of the patient. The tissue attachment member may be configured to change from the initial state to the activated state in response to an in vivo condition associated with a predetermined location in the gastrointestinal tract of the patient.
-
公开(公告)号:US20210146055A1
公开(公告)日:2021-05-20
申请号:US17094176
申请日:2020-11-10
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Ali Nekouzadeh , Susan McConnell Montalvo , Scott R. Gibson , Sheldon B. Moberg , Joshua Tamsky , Paul D. Faucher
IPC: A61M5/315
Abstract: Drug delivery devices are configured to include a gas-driven piston assembly having a flexible pushrod, a non-linear guide include a non-linear guide pathway at least partially surrounding the flexible pushrod, a cylinder at least partially surrounding the flexible pushrod, and a piston movable within the cylinder in response to the pressurized gas entering the cylinder. Some arrangements include a roller pushrod guide system and/or a gear pushrod guide system.
-
公开(公告)号:US20200164155A1
公开(公告)日:2020-05-28
申请号:US16630329
申请日:2018-08-07
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , John K. Floffman , Paul Daniel Faucher , Matthew Pacheco , Ed Maher
Abstract: A wearable drug delivery device includes a housing, a needle assembly at least partially disposed in the housing, and a drive assembly at least partially disposed in the housing and coupled to the needle assembly. The needle assembly includes a needle or cannula and a sterile barrier disposed proximal to the needle or cannula in a first configuration where the sterile barrier is intact. The drive assembly includes a container that contains a medicament to be administered, a first plunger disposed in the container, and a drive mechanism that forces the first plunger to urge the medicament through the container. Upon engaging the drive mechanism, the needle or cannula and the sterile barrier move relative to each other from the first configuration to a second configuration where the needle or cannula breaks the sterile barrier, thereby allowing the medicament to be administered via the needle or cannula.
-
公开(公告)号:US12208238B2
公开(公告)日:2025-01-28
申请号:US17360140
申请日:2021-06-28
Applicant: AMGEN INC.
Inventor: Scott Robert Gibson , Sudeshna Dutta Ray , Daniel Eduardo Groszmann , Mehran Mojarrad , Nathan Thomas Balcom , Alejandro Campillo-Agusti , Alan D. Payne , Lawrence Scott Ring
Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.
-
公开(公告)号:US12042642B2
公开(公告)日:2024-07-23
申请号:US17264157
申请日:2019-09-17
Applicant: AMGEN INC.
Inventor: Sudeshna Dutta Ray , Scott Robert Gibson , Daniel Eduardo Groszmann , Mehran Mojarrad , Andrew James Carlson , Lee Gordon Macklem , Mikhail Tikh
CPC classification number: A61M5/31576 , A61M5/14248 , A61M5/1452 , A61M2005/1585 , A61M2005/31588 , A61M2205/52
Abstract: Drug delivery devices are described that include an escapement activation assembly. The escapement activation assembly includes a slide having a plurality of pallet engagement portions and a switch engagement portion and a pallet having a plurality of slide engagement portions. A drive is coupled to the pallet to cause the pallet to move relative to the slide to move the plurality of slide engagement portions into and out of engagement with the plurality of pallet engagement portions to allow the slide to move along a path within the drug delivery device. Movement of the slide can cause the switch engagement portion to move out of engagement with an activation trigger of a mechanism of the drug delivery device.
-
公开(公告)号:US20220401643A1
公开(公告)日:2022-12-22
申请号:US17763692
申请日:2020-10-14
Applicant: AMGEN INC.
Inventor: Scott R. Gibson , Paul D. Faucher , Mehran Mojarrad
IPC: A61M5/148
Abstract: A drug delivery device includes a drug product container, a pressurized vessel, and an urging member. The drug product container can have at least one flexible wall and defining a cavity configured to contain a drug product. The pressurized vessel can contain a gas under pressure. And the urging member is in working connection with the pressurized vessel such that, upon at least partial release of the gas under pressure, the urging member moves from a first portion of the drug product container to a second portion, thereby ejecting at least a portion of the drug product from the drug product container.
-
公开(公告)号:US20220288305A1
公开(公告)日:2022-09-15
申请号:US17626667
申请日:2020-07-16
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Ali Nekouzadeh , Scott R. Gibson , Sheldon Moberg , Paul Daniel Faucher
Abstract: A drug delivery device includes a housing releasably coupled with a patient, a pressure chamber disposed in the housing and including a vent, a container at least partially disposed in the pressure chamber for storing a drug connectable in fluid communication with a fluid conduit, an activation mechanism, and a relief mechanism. The activation mechanism releases a pressurized drive fluid into the pressure chamber for expelling the drug from the container into the fluid conduit. The relief mechanism is operably coupled to the fluid conduit and is adapted to open the vent to release the drive fluid from the pressure chamber in response to a predetermined condition.
-
公开(公告)号:US11305056B2
公开(公告)日:2022-04-19
申请号:US16620016
申请日:2018-07-14
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Scott Robert Gibson , Adam Livingston
Abstract: An insertion/retraction mechanism for a drug delivery device is disclosed. The insertion/retraction mechanism includes a retraction hub, an insertion hub, an insertion/retraction mechanism housing, and a dual torsion spring system. The retraction hub includes a first primary rotational stop and a second primary rotational stop extending radially inwardly from an inside surface. The insertion hub is disposed inside the retraction hub and comprises a first complementary rotational stop and a second complementary rotational stop extending radially outwardly from an outside surface. The dual torsion spring system causes the first primary rotational stop and the second primary rotational stop to selectively engage the first complementary rotational stop and the secondary rotational stop, respectively, and further causes the retraction hub to rotate relative to the insertion/retraction mechanism housing as the insertion/retraction mechanism moves between an initial position, an inserted position, and a retracted position.
-
公开(公告)号:US20200230313A1
公开(公告)日:2020-07-23
申请号:US16620016
申请日:2018-07-03
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Scott Robert Gibson , Adam Livingston
IPC: A61M5/142
Abstract: An insertion/retraction mechanism for a drug delivery device is disclosed. The insertion/retraction mechanism includes a retraction hub, an insertion hub, an insertion/retraction mechanism housing, and a dual torsion spring system. The retraction hub includes a first primary rotational stop and a second primary rotational stop extending radially inwardly from an inside surface. The insertion hub is disposed inside the retraction hub and comprises a first complementary rotational stop and a second complementary rotational stop extending radially outwardly from an outside surface. The dual torsion spring system causes the first primary rotational stop and the second primary rotational stop to selectively engage the first complementary rotational stop and the secondary rotational stop, respectively, and further causes the retraction hub to rotate relative to the insertion/retraction mechanism housing as the insertion/retraction mechanism moves between an initial position, an inserted position, and a retracted position.
-
公开(公告)号:US11890450B2
公开(公告)日:2024-02-06
申请号:US16297408
申请日:2019-03-08
Applicant: AMGEN INC.
Inventor: Lawrence Scott Ring , Tohid Pirbodaghi , Samin Akbari , Daniel Eduardo Groszmann , Mehran Mojarrad , Mark Gordon , Mikhail Tikh , Jimmie L. Ward , Scott R. Gibson , Sheldon B. Moberg , Joshua Tamsky , Paul Faucher , Jeff Lind
CPC classification number: A61M5/16813 , A61M5/1413 , A61M5/14248 , A61M5/158 , A61M5/16822 , A61M39/24 , A61M5/14526 , A61M5/155 , A61M2005/1403 , A61M2005/1406 , A61M2005/14252 , A61M2039/244 , A61M2039/2406 , A61M2039/248 , A61M2039/2426 , A61M2205/3561 , A61M2205/505 , A61M2205/7527 , A61M2205/7536 , A61M2209/045
Abstract: A drug delivery device includes a housing defining a shell and an inner volume, a container, a drive mechanism, a needle assembly, a fluid flow connection, and a backflow prevention mechanism. The container has an inner volume to contain a medicament to be administered to a user. The drive mechanism is at least partially disposed within the housing and exerts a force to urge the medicament out the container. The fluid flow connection is coupled to the container and the needle assembly and allows the medicament to flow from the container to the needle assembly to be administered. The backflow prevention mechanism is associated with at least one of the container, the fluid flow connection, or the needle assembly and includes at least one flow restrictor to restrict a fluid from flowing from the needle assembly to the container.
-
-
-
-
-
-
-
-
-